Name | Price | Volume | Analyst Price Target | Analyst Consensus | Smart Score | Market Cap | P/E Ratio | Dividend Yield | Sector | Article | Follow |
---|---|---|---|---|---|---|---|---|---|---|---|
$114.55 | 6.47M | xxxxxxxxxxxxx | 19 Buy 5 Hold 0 Sell Strong Buy | $142.13B | 23.44 | 2.72% | Healthcare | ||||
$276.39 | 2.14M | xxxxxxxxxxxxx | 9 Buy 11 Hold 1 Sell Moderate Buy | $148.80B | 23.13 | 3.40% | Healthcare | ||||
$394.53 | 978.69K | xxxxxxxxxxxxx | 14 Buy 11 Hold 0 Sell Moderate Buy | $101.15B | 28.20 | ― | Healthcare | ||||
$144.86 | 1.81M | xxxxxxxxxxxxx | 11 Buy 14 Hold 0 Sell Moderate Buy | $21.24B | 13.86 | ― | Healthcare | ||||
$95.12 | 1.52M | xxxxxxxxxxxxx | 7 Buy 9 Hold 3 Sell Hold | $14.62B | 12.05 | ― | Healthcare | ||||
$560.00 | 602.75K | xxxxxxxxxxxxx | 17 Buy 4 Hold 1 Sell Moderate Buy | $59.35B | 14.32 | 0.47% | Healthcare | ||||
$23.51 | 31.29M | xxxxxxxxxxxxx | 2 Buy 13 Hold 3 Sell Hold | $9.15B | ― | ― | Healthcare | ||||
$187.22 | 946.28K | xxxxxxxxxxxxx | 13 Buy 4 Hold 0 Sell Strong Buy | $31.83B | 27.12 | ― | Healthcare | ||||
$96.74 | 5.15M | xxxxxxxxxxxxx | 12 Buy 4 Hold 0 Sell Strong Buy | $23.26B | ― | ― | Healthcare |
Stock | Type | Date |
---|---|---|
Gilead Sciences | Ex-Dividend Date | Sep 15, 2025 |
Biogen | Earnings Release | Oct 22, 2025 |
IQVIA Holdings | Earnings Release | Oct 22, 2025 |
Gilead Sciences | Earnings Release | Oct 23, 2025 |
Amgen | Earnings Release | Oct 29, 2025 |